Detalles de la búsqueda
1.
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.
Cancers (Basel);
16(8)2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672531
2.
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.
Blood;
143(20): 2053-2058, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38457359
3.
Integrin signaling is critical for myeloid-mediated support of T-cell acute lymphoblastic leukemia.
Nat Commun;
14(1): 6270, 2023 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805579
4.
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
Pediatr Blood Cancer;
70(12): e30672, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37710306
5.
Valosin-containing protein (VCP/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: A report from the Children's Oncology Group.
Proteomics Clin Appl;
17(6): e2200109, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287368
6.
Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group.
Int J Mol Sci;
24(6)2023 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982537
7.
DNA Damage Response-Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children's Oncology Group Study.
Int J Mol Sci;
24(6)2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36982970
8.
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells.
Blood Cancer Discov;
4(3): 208-227, 2023 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36723991
9.
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.
Pediatr Hematol Oncol;
40(2): 147-158, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838057
10.
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia.
Nat Commun;
13(1): 2801, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35589701
11.
Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
Br J Haematol;
198(1): 137-141, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35434798
12.
Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
J Clin Oncol;
40(19): 2106-2118, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35271306
13.
Clinical relevance of proteomic profiling in de novo pediatric acute myeloid leukemia: a Children's Oncology Group study.
Haematologica;
107(10): 2329-2343, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021602
14.
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Blood;
139(6): 889-893, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662378
15.
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF-κB subunit RelA.
Proteomics Clin Appl;
16(2): e2100072, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719869
16.
Reverse phase protein arrays in acute leukemia: investigative and methodological challenges.
Expert Rev Proteomics;
18(12): 1087-1097, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965151
17.
Comparison of the blood, bone marrow, and cerebrospinal fluid metabolomes in children with b-cell acute lymphoblastic leukemia.
Sci Rep;
11(1): 19613, 2021 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608220
18.
Rational biomarker development for the early and minimally invasive monitoring of AML.
Blood Adv;
5(21): 4515-4520, 2021 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34587228
19.
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependency.
Blood Adv;
5(23): 4864-4876, 2021 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543389
20.
The Anti-Tumor Activity of the NEDD8 Inhibitor Pevonedistat in Neuroblastoma.
Int J Mol Sci;
22(12)2021 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34207315